Multiple Post-SARS-COV2 Infectious Complications in Kidney Transplant Recipient

Grzejszczak, Patrycja; Płuciennik, Agnieszka; Kumor-Kisielewska, Anna; Kurnatowska, Ilona

doi:10.3390/medicina58101370

Cited by 2 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Tese reports were obtained during the early phase of the SARS-CoV-2 pandemic (to mid-2022) when the mortality rate was higher than that of the current pandemic (after late 2022, the Omicron phase). Although these reports [8][9][10] did not include SARS-CoV-2 patient vaccination data, a rare case of SARS-CoV-2 coinfection with CMV reactivation in an immunocompromised patient who received the SARS-CoV-2 vaccination was also reported [11].…”

Section: Discussionmentioning

confidence: 99%

Coinfection with SARS-CoV-2 and Cytomegalovirus in a Patient with Mild COVID-19

Ura,

Goubaru,

Motoya

et al. 2023

Case Reports in Infectious Diseases

View full text Add to dashboard Cite

Persistent fever due to coronavirus disease 2019 (COVID-19) is a considerable issue for patients and physicians that requires a broad differential diagnosis and evaluation of complications. Coinfections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and various respiratory viruses have also been reported. In severe cases of COVID-19, cytomegalovirus (CMV) reactivation or CMV coinfection with SARS-CoV-2 has been reported in association with critical illnesses and immunosuppressive therapy; however, in mild COVID-19 cases, CMV coinfection with SARS-CoV-2 has been reported only in severely immunocompromised patients, and its incidence and clinical importance remain unclear. Herein, we report a rare case of coinfection with SARS-CoV-2 and CMV in a patient with mild COVID-19 and untreated diabetes mellitus, which led to persistent fever for approximately 4 weeks. CMV coinfection should be considered in patients with COVID-19 who exhibit persistent fever.

show abstract

Section: Discussionmentioning

confidence: 99%

Coinfection with SARS-CoV-2 and Cytomegalovirus in a Patient with Mild COVID-19

Ura,

Goubaru,

Motoya

et al. 2023

Case Reports in Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…Although these reports [26][27][28] did not include data on the patients receiving vaccination against COVID-19. A rare case of SARS-CoV-2 coinfection with CMV reactivation in an immunocompromised patient after getting COV-ID-19 vaccination has been reported [29].…”

Section: Ahmed Et Almentioning

confidence: 99%

Cytomegalovirus Colitis in an Immunocompetent Patient Following COVID-19

Ahmed,

Malik,

Ahmed

et al. 2024

Clin Infect Immun

View full text Add to dashboard Cite

Colitis due to cytomegalovirus (CMV) in immunocompetent patients is an infrequent occurrence and is associated with medical conditions that cause immunodepression, such as diabetes mellitus, prolonged residence in the intensive care unit, autoimmune diseases, organ failure, etc. The immune imbalance noticed in patients with severe coronavirus disease 2019 (COVID-19) can lead to co-infection or reactivation of CMV. But CMV colitis following a recent COVID-19 is extremely rare. We present a case of an elderly female, who recently had COVID-19 and was evaluated for nausea vomiting and abdominal pain. Colonoscopy showed severe inflammation and congested mucosa and histopathological analysis of the biopsy specimen confirmed the diagnosis of CMV colitis. The patient had an excellent response to oral ganciclovir therapy. This case highlights the importance of suspecting CMV colitis in patients with recent COVID-19 presenting with nonspecific symptoms, such as in our case of nausea, vomiting, and abdominal pain and pancolitis on imaging, as early diagnosis is the key to improved outcomes.

show abstract

Multiple Post-SARS-COV2 Infectious Complications in Kidney Transplant Recipient

Cited by 2 publications

References 23 publications

Coinfection with SARS-CoV-2 and Cytomegalovirus in a Patient with Mild COVID-19

Coinfection with SARS-CoV-2 and Cytomegalovirus in a Patient with Mild COVID-19

Cytomegalovirus Colitis in an Immunocompetent Patient Following COVID-19

Contact Info

Product

Resources

About